Insider Selling: Nutex Health (NASDAQ:NUTX) Director Sells $43,492.75 in Stock

Nutex Health Inc. (NASDAQ:NUTX) Director Scott Saunders sold 203 shares of the business’s stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the transaction, the director owned 400 shares in the company, valued at $85,700. This trade represents a 33.67% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.

Nutex Health Trading Down 2.6%

Shares of NUTX traded down $5.53 during trading hours on Friday, hitting $208.79. 246,698 shares of the stock were exchanged, compared to its average volume of 170,645. Nutex Health Inc. has a fifty-two week low of $83.99 and a fifty-two week high of $224.28. The business has a 50-day moving average of $179.08 and a 200-day moving average of $143.31. The firm has a market capitalization of $1.43 billion, a P/E ratio of 8.20 and a beta of 0.28. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. On average, research analysts expect that Nutex Health Inc. will post 27.58 EPS for the current year.

Wall Street Analysts Forecast Growth

NUTX has been the topic of several research analyst reports. B. Riley Financial upped their target price on Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a research report on Friday, September 4th. Zacks Research raised Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Lake Street Capital restated a “buy” rating and set a $310.00 price target (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. Wall Street Zen downgraded shares of Nutex Health from a “buy” rating to a “hold” rating in a research report on Saturday, September 5th. Finally, B Riley reiterated a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, Nutex Health presently has a consensus rating of “Buy” and a consensus price target of $317.50.

Institutional Trading of Nutex Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. BlackRock Inc. acquired a new position in Nutex Health during the 2nd quarter worth approximately $69,612,000. Winmill & CO. Inc. acquired a new stake in Nutex Health in the second quarter valued at approximately $11,168,000. Empowered Funds LLC bought a new stake in shares of Nutex Health during the second quarter valued at approximately $7,720,000. Pacer Advisors Inc. increased its holdings in shares of Nutex Health by 4.3% during the fourth quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock valued at $5,480,000 after acquiring an additional 1,359 shares in the last quarter. Finally, Bank of New York Mellon Corp acquired a new position in shares of Nutex Health during the second quarter worth approximately $3,956,000. 5.32% of the stock is owned by institutional investors.

About Nutex Health

Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.